Keros Therapeutics, Inc. (KROS) shares outstanding

Shares outstanding · fiscal 2025
37.86M

Keros Therapeutics, Inc. (KROS) had 37.86M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 1.1% higher than the 37.44M of fiscal 2024. Figures as of 18 Nov 2026, 12:21 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
37.86M
Change on fiscal 2024
+1.1%
Growth, 5 years
+19.5% a year
Highest on record
37.86Mfiscal 2025
Lowest on record
15.51Mfiscal 2020
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Keros Therapeutics, Inc. shares outstanding, in more detail

The market data feed counts 19.62M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count grew at a compound 19.5% a year. Across the 6 fiscal years on record (2020–2025), the highest was 37.86M in fiscal 2025 and the lowest 15.51M in fiscal 2020.

History · 6 fiscal years

Shares outstanding by fiscal year

Keros Therapeutics, Inc. shares outstanding, year by year

Keros Therapeutics, Inc. (KROS) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
202537.86M 1.1% up
202437.44M 27.1% up
202329.45M 25.7% up
202223.44M 0.4% up
202123.33M 50.5% up
202015.51M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

More on KROS

Keros Therapeutics, Inc., figure by figure

Keros Therapeutics, Inc. (KROS) overview: price, valuation and scorecard

Keros Therapeutics, Inc. shares outstanding: questions and answers

How many shares does Keros Therapeutics, Inc. have?

Keros Therapeutics, Inc. (KROS) had 37.86M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 1.1% higher than the 37.44M of fiscal 2024. The market data feed counts 19.62M shares outstanding today.

What is the growth rate of Keros Therapeutics, Inc.'s diluted share count?

Over the five fiscal years to 2025 the diluted share count grew at a compound 19.5% a year.

What are the highest and lowest diluted share count figures on record for Keros Therapeutics, Inc.?

Across the 6 fiscal years on record (2020–2025), the highest was 37.86M in fiscal 2025 and the lowest 15.51M in fiscal 2020.

How is Keros Therapeutics, Inc.'s diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Keros Therapeutics, Inc. it is on record here for 6 fiscal years, 2020 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Keros Therapeutics, Inc. (KROS) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/KROS/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.